AIMC Topic: Cyclic Nucleotide Phosphodiesterases, Type 5

Clear Filters Showing 1 to 3 of 3 articles

Editorial Comment from Dr Matsushita to Impact of penile rehabilitation with phosphodiesterase-5 inhibitors on recovery of erectile function in patients undergoing robot-assisted radical prostatectomy: A propensity score-matched analysis.

International journal of urology : official journal of the Japanese Urological Association Mar 13, 2021
Humans Male Robotics Propensity Score Prostatectomy Erectile Dysfunction Penile Erection Phosphodiesterase 5 Inhibitors Cyclic Nucleotide Phosphodiesterases, Type 5
View on PubMed DOI

Editorial Comment from Dr Hinata to Impact of penile rehabilitation with phosphodiesterase-5 inhibitors on recovery of erectile function in patients undergoing robot-assisted radical prostatectomy: A propensity score-matched analysis.

International journal of urology : official journal of the Japanese Urological Association Mar 4, 2021
Humans Male Robotics Propensity Score Prostatectomy Erectile Dysfunction Penile Erection Phosphodiesterase 5 Inhibitors Cyclic Nucleotide Phosphodiesterases, Type 5
View on PubMed DOI

Impact of penile rehabilitation with phosphodiesterase-5 inhibitors on recovery of erectile function in patients undergoing robot-assisted radical prostatectomy: A propensity score-matched analysis.

International journal of urology : official journal of the Japanese Urological Association Mar 4, 2021
OBJECTIVE: To investigate the impact of penile rehabilitation on the recovery of erectile function after robot-assisted radical prostatectomy.
Humans Male Recovery of Function Robotics Prostatic Neoplasms Propensity Score Prostatectomy Erectile Dysfunction Penile Erection Phosphodiesterase 5 Inhibitors Cyclic Nucleotide Phosphodiesterases, Type 5
View on PubMed DOI
Popular Topics
Recent Journals